Showing results (1-10 of 48) with videos related to
Sort By:
Pageof 5
Cardiovascular Drugs and Therapy|November 1, 1993
Modifying serum lipids to prevent coronary heart disease: do we have a consensus?S A GroverDrug Safety|April 1, 1994
Risk-benefit assessment of drug treatment to prevent coronary heart disease. Estimating the benefits of risk factor modificationS A Grover, L CoupalCMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 1, 1996
Use of the emergency department for nonurgent care during regular business hoursM G Burnett, S A GroverJournal of Clinical Epidemiology|February 11, 1999
Identifying adults at low risk for significant hyperlipidemia: a validated clinical indexS A Grover, C Levinton, S PaquetJournal of Clinical Epidemiology|February 1, 1996
Relationship between dietary intake and coronary heart disease mortality: lipid research clinics prevalence follow-up studyK L Esrey, L Joseph, S A GroverArchives of Internal Medicine|March 28, 1994
Serum lipid screening to identify high-risk individuals for coronary death. The results of the Lipid Research Clinics prevalence cohortS A Grover, C S Palmer, L CoupalAmerican Journal of Public Health|January 1, 1988
The impact of Medicare on early cancer detection in the elderlyS A Grover, E F Cook, L GoldmanJAMA|September 13, 1995
Identifying adults at increased risk of coronary disease. How well do the current cholesterol guidelines work?S A Grover, L Coupal, X P HuAmerican Journal of Epidemiology|April 15, 1997
Flexible modeling of the effects of serum cholesterol on coronary heart disease mortalityM Abrahamowicz, R du Berger, S A GroverCirculation|August 16, 2000
Cost-effectiveness of treating hyperlipidemia in the presence of diabetes : who should be treated?S A Grover, L Coupal, H Zowall, et al.Pageof 5